Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
When talking about infectious keratitis in the U.S., this usually refers to bacterial keratitis, which has a higher incidence than fungal keratitis. However, there are reportedly 30,000–40,000 new cases of fungal keratitis annually, so it’s still a significant number.
➤ Long-term safety, efficacy data reported from standalone MIGS procedure ➤ Positive clinical data in ongoing trial for investigational thyroid eye disease treatment ➤ Bioengineered cornea restores vision in 20 people ➤ ASCRS news and events
More than 2 years after being blinded in a “freak fireworks accident,” European football player Omar Elabdellaoui received a vision-restoring corneal transplant performed by Edward Holland, MD.
➤ Topline results from Phase 3 pivotal trial evaluating mydriasis drug ➤ First person dosed in Phase 3 trial for first-in-class dry eye candidate ➤ Phase 2 study of a novel glaucoma drop targeting non-traditional outflow ➤ Digital vision screening platform with machine learning ➤ Alcon to acquire dry eye drop and inflammation/pain drop ➤ New issue online ➤ ASCRS news and events
Cornea Editor Clara Chan, MD, talks about her experience incorporating new techniques and technologies into her practice and previews the articles in the section.
Scleral lenses are an option that many physicians use to help patients suffering from more severe and advanced cases of dry eye disease. Two ophthalmologists discussed the options and how these fit into the treatment of dry eye.
New diagnostic techniques are often developed when a need in the clinic or OR arises. That is what led one physician to develop the corneal sweep test and a new diagnostic tool to identify recurrent corneal erosion.
➤ Roberto Zaldivar, MD, delivers the Steinert Lecture ➤ Richard Lindstrom, MD, gives Obstbaum Lecture ➤ Video cases offer a ‘Reay of Hope’ at Glaucoma Day ➤ Cornea Day covers topics in keratoconus, corneal ectasia, lamellar surgery
Restasis (cyclosporine ophthalmic emulsion) was developed by Allergan and approved by the U.S. FDA in 2003. Now, after nearly 2 decades since its approval as a brand name drug indicated for symptoms of dry eye, a generic version of Restasis has been approved. It was a “long time coming,” according to Henry Perry, MD.
➤ Topline data from Phase 3 trial of presbyopia-correcting drop ➤ FDA gives 510(K) approval to updated neuromodulation therapy for increased tear production ➤ Enrollment complete for Phase 3 trial of reproxalap ➤ DME trial to focus on underrepresented patient populations ➤ BLA submitted to FDA for wet AMD therapy ➤ Companies collaborate to further develop gene therapy for retinal disease ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.